What is Zip Drug Testing?
Zip Drug Testing, LLC. operates as a specialized provider of mobile and on-demand diagnostic services, catering to both individual requirements and complex enterprise-level workforce safety protocols. By prioritizing accessibility and speed, the company has carved out a distinct market position, offering 24/7 collection services that minimize downtime for corporate clients. Their business model effectively bridges the gap between traditional laboratory testing and the modern demand for immediate, location-agnostic health verification, making them a critical partner for organizations maintaining strict safety standards.
How much funding has Zip Drug Testing raised?
Zip Drug Testing has raised a total of $1.4M across 1 funding round:
Debt
$1.4M
Debt (2025): $1.4M with participation from Texas Capital Bank
Key Investors in Zip Drug Testing
Texas Capital Bank
A prominent financial institution providing comprehensive banking and capital solutions, often supporting growth-oriented enterprises through strategic debt financing.
What's next for Zip Drug Testing?
With this major enterprise-level funding, Zip Drug Testing is expected to accelerate its infrastructure development and geographic reach. The strategic capital will likely be deployed to enhance their mobile collection fleet and integrate advanced digital scheduling platforms, further streamlining the client experience. As the demand for reliable, rapid drug testing continues to rise within the logistics, construction, and healthcare sectors, the company is poised to scale its operations to meet increasing enterprise compliance needs, solidifying its role as a leader in the mobile diagnostic space.
See full Zip Drug Testing company page
